An empty hospital operating theatre

For boards, CISOs, device security leads and data protection officers in healthcare and life sciences

Quantum risk in healthcare and life sciences

Patient data outlives the encryption that protects it.

In fifteen minutes you will know which patient, genomic and trial records are already exposed, what HIPAA, the FDA, EU MDR and NIS2 let a regulator ask for, and the first 90 days of a post-quantum plan your board can sign off.

  • Your exposure, record type by record type
  • The evidence regulators and auditors can ask for
  • A board-ready 90-day plan
  • The right training for each role
1,500+
professional members
900+
organisations represented
40+
countries
Vendor-neutral
based on evidence, not hype

Proud to recommend our expert members

Qrypto Cyber
Eclypses
Arqit
QuantBond
Krown
Applied Quantum
Quantum Bitcoin
Venari Security
QuStream
BHO Legal
Census
QSP
IONQ - ID Quantique
Patero
Entopya
Belden
Atlant3D
Zenith Studio
Qudef
Aries Partners
GQI
Upperside Conferences
Austrade
Arrise Innovations
CyberRST
Triarii Research
QSysteme
WizzWang
DeepTech DAO
Xyberteq
Viavi
Entrust
Qsentinel
Nokia
Gopher Security
Quside
QIZ
Global Quantum Intelligence
Qrypto Cyber
Eclypses
Arqit
QuantBond
Krown
Applied Quantum
Quantum Bitcoin
Venari Security
QuStream
BHO Legal
Census
QSP
IONQ - ID Quantique
Patero
Entopya
Belden
Atlant3D
Zenith Studio
Qudef
Aries Partners
GQI
Upperside Conferences
Austrade
Arrise Innovations
CyberRST
Triarii Research
QSysteme
WizzWang
DeepTech DAO
Xyberteq
Viavi
Entrust
Qsentinel
Nokia
Gopher Security
Quside
QIZ
Global Quantum Intelligence
Brain scans laid out on a lightbox
Copied this year. Read in a decade. Still about the same patient.

Step 1 of 5

Know which patient records are already exposed

The attacker does not wait for a quantum computer. They copy your encrypted traffic and backups now and read them when one arrives. A bank statement from 2026 will be stale by then. A child's medical history, a maternity record or a whole-genome sequence will not. Healthcare keeps data longer than almost any other sector, and the people in those records are still alive when the cryptography fails.

Health and life sciences records that must stay confidential beyond the post-quantum deadlines
Record typeTypical retentionConfidential until, if created in 2026
GP patient records, England (NHS Records Management Code of Practice)10 years after the patient's deathThe patient's lifetime plus 10 years
Maternity records, England (NHS code)25 years after the birth of the last child2051+
Whole-genome sequences and biobank dataNo end date: a genome does not change, and it describes the patient's relatives tooIndefinitely
Clinical trial master file (EU Clinical Trials Regulation, Article 58)At least 25 years after the end of the trial2051+ for a trial ending in 2026
US adult medical records (state law; hospitals keep at least 5 years under 42 CFR 482.24)Commonly 7 to 10 years from last treatment, longer for minors2033 to 2045+
Medicare Advantage plan records (42 CFR 422.504(d))10 years2036+
Medical device technical documentation (EU MDR Article 10(8))10 years after the last device is placed on the market, 15 years for implantables2036 to 2041+, longer while the product line still sells

Retention rules from the NHS England Records Management Code of Practice, Regulation (EU) 536/2014, 42 CFR and Regulation (EU) 2017/745, linked in the library below. The patient and genomic data workshop works through your own record types. Read the HIPAA analysis for the US position.

Where your exposure sits, and what you will know

A CT scanner in a hospital imaging room

Connected medical devices

An imaging system, infusion pump or implant bought in 2026 is often still in clinical use in 2040, running the cryptography it shipped with.

You will know which device families can change algorithm in the field, which must be bought crypto-agile, and which need ring-fencing until they retire.

A long, brightly lit hospital corridor

EHR, portals and health information exchange

Patient portals, FHIR APIs and exchange gateways face the internet and carry the records with the longest lives. The cryptography inside a hosted EHR belongs to the vendor, not to you.

You will know which external interfaces move to hybrid key exchange first, and which vendor roadmap sets your timeline.

A hand lifting a test tube from a rack in a laboratory

Genomic, trial and pharma data

Genomes never expire, trial master files last 25 years and a formulation or a trial result is worth copying the day it is created.

You will know which archives to re-encrypt or move behind quantum-safe keys first, and how to sign regulatory submissions so they still verify in 2040.

Free readiness check

Score your organisation in two minutes

Eight questions mapped to what a HIPAA auditor, a NIS2 competent authority, a notified body or your board can ask about quantum risk. You get a score, your top three priorities and the next step that closes your biggest gap. Nothing is sent anywhere.

Start the check
1Do you have a cryptographic inventory covering your EHR, patient portals, exchange interfaces and connected device fleet?

The proposed HIPAA Security Rule update would require a technology asset inventory and a map of how ePHI moves through your systems. NIS2 Article 21 asks for the same discipline from essential entities.

2Have you identified which data must stay confidential beyond 2030: genomic, paediatric, maternity, mental health and trial data?

Records with lifetime retention are exposed today to harvest now, decrypt later collection, whatever happens to the quantum timeline.

3Does your HIPAA or GDPR risk analysis name harvest now, decrypt later and quantum cryptanalysis?

45 CFR 164.308(a)(1)(ii)(A) requires an accurate and thorough risk analysis, and GDPR Article 32 measures security against the state of the art. Neither can ignore a threat that is already published.

4Has your EHR vendor, and the cloud host behind it, given you a post-quantum roadmap in writing?

In a hosted EHR the cryptography protecting ePHI is under the vendor's control. The Business Associate Agreement is the instrument for asking.

5Does your device procurement standard require algorithms that stay current for the service life, and a way to update them?

The FDA's February 2026 premarket guidance asks manufacturers for cryptography expected to stay strong throughout the service life of the device. A device bought in 2027 with a twelve-year life runs past the 2035 disallow date.

6Is there a named owner and a budget line for post-quantum migration?

Programmes without an owner stall at the inventory stage, and in healthcare the inventory alone crosses clinical engineering, IT and the EHR team.

7Has your board or management body been briefed on quantum risk in the last 12 months?

NIS2 Article 20 makes management bodies approve and oversee cybersecurity risk measures, and lets member states hold them liable. HHS has proposed annual compliance audits.

8Could you replace an algorithm in a key clinical system without re-engineering it?

Crypto-agility decides whether migration takes months or years, and whether a device recall becomes a firmware update.

Step 2 of 5

Know what regulators and your board will expect, and when

  1. 2024

    Standards final

    NIST publishes FIPS 203, 204 and 205. NIS2 transposition deadline passes on 17 October.

  2. 2025

    HIPAA rewrite proposed

    HHS proposes mandatory encryption of ePHI, an asset inventory and a network map. The NCSC publishes its 2028, 2031 and 2035 timeline.

  3. 2026

    Devices for the service life

    FDA guidance asks for cryptography that stays strong for the device's service life. The EU roadmap asks organisations to start.

  4. 2028

    UK discovery done

    The NCSC expects you to know your cryptography and have a plan.

  5. 2030

    High-risk migrated

    EU target for high-risk systems. NIST deprecates 112-bit RSA and ECC. EHDS cross-border exchange is live from March 2029.

  6. 2035

    RSA and ECC disallowed

    NIST disallows them. EU and NCSC timelines end here, while devices bought today are still on the ward.

Key facts for healthcare and life sciences, checked 30 October 2026

  • HHS published a proposed update to the HIPAA Security Rule on 6 January 2025 that would expressly require regulated entities to encrypt ePHI, with limited exceptions, and to inventory technology assets and map the movement of ePHI. Federal Register
  • Section 524B of the FD&C Act has applied to premarket submissions for cyber devices since 29 March 2023: a plan for postmarket vulnerabilities, reasonable assurance of cybersecurity and a software bill of materials. FDA
  • The FDA's premarket cybersecurity guidance of 3 February 2026 asks for cryptography expected to remain strong throughout the service life of the device, and no deprecated or disallowed algorithms. FDA
  • NIS2 lists healthcare providers, pharmaceutical manufacturers and critical medical device makers as sectors of high criticality, and Article 21(2)(h) names cryptography and encryption among the required measures. EUR-Lex
  • The European Health Data Space Regulation entered into force on 26 March 2025. Cross-border exchange of patient summaries and ePrescriptions applies from March 2029, and genomic data joins secondary use from March 2031. European Commission
  • NIST IR 8547 deprecates 112-bit RSA and ECC after 2030 and disallows them after 2035. NIST
  • The UK NCSC expects discovery and a plan by 2028, high-priority migration by 2031 and completion by 2035. UK NCSC
Workers in protective suits at a sterile pharmaceutical production line

The evidence you will be able to show an auditor, an authority or a notified body

HIPAA 45 CFR 164.308(a)(1)

A risk analysis that names the quantum threat

You show: A Security Rule risk analysis that lists harvest now, decrypt later exposure for long-lived ePHI, and the migration plan that answers it.

HIPAA proposed rule, 2025

An asset inventory and a data-flow map

You show: A technology asset inventory and a map of how ePHI moves, with the cryptography on each link recorded.

FD&C Act 524B and FDA guidance

Device cryptography that lasts the service life

You show: For devices you make: algorithms current to 2035 and a path to update them. For devices you buy: procurement language that asks for the same.

NIS2 Articles 20 and 21, MDR Annex I 17.2

A cryptography policy approved at the top

You show: An encryption policy that names quantum cryptanalysis and the NIST standards, approved by the management body, and device documentation that treats information security as state of the art across the life cycle.

A CT scanner in a hospital imaging room

NHS organisations. The Data Security and Protection Toolkit (2026-27, version 9) is the annual assessment every organisation with access to NHS patient data must complete, with CAF-aligned audit guidance. Neither it nor the DHSC cyber security strategy for health and social care to 2030 names post-quantum cryptography yet, so the NCSC timeline sets the pace: discovery by 2028, priority migration by 2031, done by 2035. Trusts that hold genomic or paediatric data should treat 2028 as the deadline for knowing where it is encrypted and by what. Read the NCSC guidance explained or see our workshops for healthcare teams.

Medical device makers

Section 524B applies to any device with software that can connect to the internet. The February 2026 FDA guidance adds the test that matters for quantum: cryptography expected to stay strong for the service life, and nothing on the NIST SP 800-131A deprecated list. With RSA and ECC deprecated after 2030, a device filed in 2027 with a ten-year life needs ML-KEM and ML-DSA in its design, or a documented way to update. In the EU, MDR Annex I section 17.2 and MDCG 2019-16 ask for information security to the state of the art across the life cycle. Medical device and IoMT workshop.

Pharma and clinical research

Regulation (EU) 536/2014 Article 58 keeps the trial master file for at least 25 years after a trial ends. US submissions under 21 CFR Part 11 rely on electronic signatures that must still verify when a regulator reopens the file. Both point the same way: trial archives and regulatory submissions need quantum-safe encryption and ML-DSA or SLH-DSA signatures before anything else in the estate. Clinical trial data workshop.

Health insurers and payers

Health plans are HIPAA covered entities in their own right, and Medicare Advantage organisations keep records for 10 years under 42 CFR 422.504(d). Claims clearinghouses and eligibility links move ePHI between hundreds of counterparties, so a payer's migration is set by the slowest provider and clearinghouse on the network, which makes the vendor questionnaire the first task, not the last.

The European Health Data Space

EHDS obliges EHR systems and member state infrastructures to exchange patient summaries and ePrescriptions across borders from March 2029, with images, lab results and discharge reports following in 2031 and genomic data entering secondary use the same year. Infrastructure built between now and 2029 should be built on hybrid post-quantum key exchange from the first design review, because its data lives for decades. EHR PQC migration workshop.

What health systems, regulators and pharma are already doing

Public post-quantum work across the sector, so you can benchmark where your organisation stands.

September 2026

HHS ASPR

Told the Health IT Summit it is about to release post-quantum migration guidance for hospitals and public health organisations, and that inventorying data and systems is the preparation to start now.

Source: GovCIO Media →
February 2026

US FDA

Reissued its premarket cybersecurity guidance with recommendations under section 524B, asking for cryptography expected to remain strong throughout the service life of the device.

Source: FDA →
June 2025

IonQ, AstraZeneca, AWS and NVIDIA

Simulated a key step of a Suzuki-Miyaura reaction, used in small-molecule drug synthesis, on a hybrid quantum and GPU stack and reported a more than 20-fold improvement in time to solution over earlier benchmarks. Vendor-reported, not independently verified.

Source: IonQ →
August 2023

American Hospital Association

Urged hospitals to build a quantum-readiness roadmap covering cryptographic inventories, vendor relationships and supply chain, after CISA, the NSA and NIST published their quantum-readiness factsheet.

Source: AHA →
March 2022

Mount Sinai Health System

Announced it would incorporate post-quantum cryptography protocols into its network, among the first health systems to do so, starting with discovery of the software that needs updating.

Source: SandboxAQ →

Step 3 of 5

Build a plan your board can sign off in 90 days

By day 30

It has an owner and a scope

  • A programme owner and a sponsor on the board or management body.
  • Inventory scoped to the EHR, patient portals, exchange interfaces and the connected device fleet.
  • Record types mapped to retention periods, genomic and paediatric data first.
By day 60

You have the evidence

  • Discovery running and the cryptographic inventory started, with clinical engineering in the room.
  • A post-quantum questionnaire with your EHR vendor, cloud host, device suppliers and claims clearinghouse.
  • The HIPAA risk analysis or GDPR Article 32 assessment updated to name quantum cryptanalysis.
By day 90

Your board has a plan to approve

  • Systems ranked by data lifetime and exposure.
  • Hybrid key exchange piloted on one patient portal or exchange gateway.
  • A device procurement standard and a roadmap with 2030 and 2035 milestones, ready for sign-off.
Who will deliver it? See step 4 →

The five numbers to show your board

  1. Inventory coverageThe share of systems that hold or move ePHI, and of the connected device fleet, with a completed cryptographic inventory.
  2. Exposed recordsThe record types, and patient counts, that must stay confidential beyond 2030, led by genomic, paediatric and maternity data.
  3. Vendor readinessHow many of your EHR, cloud, device and clearinghouse suppliers have a post-quantum roadmap on file.
  4. Device fleetHow many connected devices can change algorithm in the field, and how many have a retirement date before 2035.
  5. Plan statusBudget committed and milestones met against the 2030 and 2035 deadlines.

How to phase the spend, 2026 to 2035

  1. 2026Discover and planOwner, inventory, data-lifetime map and vendor questionnaire, in line with the EU first-steps milestone and ahead of the NCSC 2028 date.
  2. 2027Policy, contracts and pilotsEncryption policy updated, PQC clauses in Business Associate Agreements and device contracts, a procurement standard, hybrid pilots on portals and gateways.
  3. 2028 to 2030Migrate high-risk systemsPatient-facing portals, exchange gateways, genomic and trial archives first, to meet the EU 2030 target and NIST deprecation.
  4. 2031 to 2035Complete the estateInternal clinical systems migrated, and every device that cannot change algorithm retired or ring-fenced before RSA and ECC are disallowed in 2035.

For budget ranges, see our PQC migration cost benchmarks. For a plan built around your trust, hospital group or product line, see the healthcare workshops.

Free tools to do it this quarter

Need help delivering the plan? Our expert members are peer-reviewed suppliers, integrators and advisers. Meet the expert members →

Step 4 of 5

Equip the people who will deliver it

A migration succeeds or stalls on people. In healthcare that means the programme lead, the board, the security team and clinical engineering working from one plan.

For your programme lead

Your programme lead can run the migration to the 2030 deadlines

  • Inventory and CBOM auditing across the EHR, portals, exchange interfaces and the device fleet
  • Risk prioritisation by data lifetime, with genomic and paediatric data first
  • Crypto-agile architecture and GRC integration for HIPAA, NIS2 and MDR evidence
  • Supplier management for EHR, cloud and device vendors, and a tabletop exercise with your scenario

CPQCPM, Certified Post Quantum Cryptography Programme Manager. Ten hours live online over five weeks, small cohorts, delivered by Chris Basener of Argus Advisory and certified by QSECDEF. See the full course →

$1,450 a seat · $1,087.50 for members

QSECDEF training · CPQCPM

Watch the overview, then get the brochure, dates and costs

Your brochure, the next cohort dates and the costs are ready on the next page.

We use your email to send QSECDEF updates and news. See our privacy policy.

Board and executives

Your board can challenge the plan, weigh quantum computing claims from pharma and device vendors, and approve the budget with confidence.

Certified Quantum Business Professional

Self-paced, no physics background. Covers PQC, policy and PQC risk and migration management.

Free first session · included in membership

Get Session 1 free
Security, IT and clinical engineering teams

Your teams understand the threat, the standards and the tools before they touch a clinical system.

Introduction to Quantum Cyber Security

Six modules, 4 to 5 hours, certificated.

Free first module · included in membership

Get Module 1 free
GRC, privacy and compliance leads

Your GRC team connects HIPAA, NIS2, the AI Act's rules for medical AI and the PQC timeline in one view.

AI Security and Resilience Leadership Bootcamp

Ten weeks, live, with the CASRP credential.

Live sessions free to attend

Join the free live sessions
Colleagues working together at a table with a laptop

Training the whole team? Put everyone on one plan.

Team membership brings your board, programme lead, security team and clinical engineers up to speed together, tracks what each person has completed and certifies across the group. The three courses above are included, plus 170+ expert lectures and the weekly call, and members pay less for CPQCPM.

See team membership

Step 5 of 5

Compare notes with health leaders who have already started

A members-only structured Q&A for executives, CISOs, device product security leads and data protection officers at hospital groups, health systems, insurers, genomics organisations, device makers and pharmaceutical companies. It runs under the Chatham House Rule and is facilitated by Anna Beata Kalisz Hedegaard, Founder of QSECDEF.

  • A sequencing framework for EHR interfaces, the device fleet and genomic archives
  • A read on where peers are placing their migration budgets, and what their EHR vendors have said
  • What auditors and notified bodies are starting to ask about cryptography
  • A realistic read on quantum drug discovery and clinical quantum machine learning, separated from vendor claims
A QSECDEF symposium panel on stage in front of an audience
Practitioner panels, on the record
QSECDEF members and speakers together outside the Arc de Triomphe in Paris
Peers you can call afterwards
Panellists in discussion at a QSECDEF symposium
Questions taken from the floor
A speaker presenting slides at the QSECDEF World Symposium
Briefings on what is changing
A keynote speaker at the QSECDEF World Symposium lectern
QSECDEF World Symposium, Paris

Lectures from people doing this work

Practitioner lectures from the QSECDEF library that matter most to healthcare and life sciences: a sober read on the threat, how to run a migration programme, how to protect data and devices, and what quantum computing can and cannot yet do for research.

Browse all expert lectures

Expert contributors represent leading organisations worldwide

Airbus Central R&T
Aireon
Airesatech
Ait
Appliedquantum
Arise Innovations
Arobs
Arqit
Asc Csa
Atlant3D
Bank of Ireland
Barak Azar
Basener Consulting
BHO Legal
Bitcoinqs
Bloq
Buckingham
CloudTech Group
Coherent Computing
Creotech
Cryptalabs
CyberProtonics
Cysec
Cystel
Deimos Space
Department of Digitalization
Dhbw
Dlr
Eclypses
Elpromaelectronics
Engineering
Enluzstrategy
Entrokey Labs
Eptalent
ESA
Esa
Euc
EXATEL
Finqbit
Fraunhofer
Georgetown
GQI
Helix Ft
Ibm
Idquantique
Jagiellonian University
Jos Quantum
Kets Quantum
Kit
Krown Technologies
Kwantumg
Lightriderinc
Linkedin
Lnu
Mbda Systems
Meetiqm
Merqury
Metrosert
Molket
Nicolaus Copernicus University in Torun
Nokia
Orcacomputing
Osi
Pantherun
Patero
Photonics Foundry
Q Ctrl
Qryptocyber
Qssys
Qticompany
Qtlabs
Quandela
Quant X Sec
Quant.Bond
Quantivate
Quantum Computing Inc
Quantum Dice
Quantumbrilliance
Quantumprime
Quantzen
Qubridge
Qudef
Quranium
Qustream
Reddixgroup
Slater Technologies
Smartcyber Group
Smoad
Sparkle
Swiss Financial Innovation Desk
Technology Innovation Institute (TII)
Thequantuminsider
Tobias Heindel
Tu Braunschweig
University College London
University of Bremen
University of Pisa
Venari Security
Veriqloud
Viavisolutions
Vodafone
Welinq
Wizzwang
Xairos
Youtube
Quside
QIZ
Global Quantum Intelligence
HYPATIA Smart Technologies
SAS
Triarii Research
Airbus Central R&T
Aireon
Airesatech
Ait
Appliedquantum
Arise Innovations
Arobs
Arqit
Asc Csa
Atlant3D
Bank of Ireland
Barak Azar
Basener Consulting
BHO Legal
Bitcoinqs
Bloq
Buckingham
CloudTech Group
Coherent Computing
Creotech
Cryptalabs
CyberProtonics
Cysec
Cystel
Deimos Space
Department of Digitalization
Dhbw
Dlr
Eclypses
Elpromaelectronics
Engineering
Enluzstrategy
Entrokey Labs
Eptalent
ESA
Esa
Euc
EXATEL
Finqbit
Fraunhofer
Georgetown
GQI
Helix Ft
Ibm
Idquantique
Jagiellonian University
Jos Quantum
Kets Quantum
Kit
Krown Technologies
Kwantumg
Lightriderinc
Linkedin
Lnu
Mbda Systems
Meetiqm
Merqury
Metrosert
Molket
Nicolaus Copernicus University in Torun
Nokia
Orcacomputing
Osi
Pantherun
Patero
Photonics Foundry
Q Ctrl
Qryptocyber
Qssys
Qticompany
Qtlabs
Quandela
Quant X Sec
Quant.Bond
Quantivate
Quantum Computing Inc
Quantum Dice
Quantumbrilliance
Quantumprime
Quantzen
Qubridge
Qudef
Quranium
Qustream
Reddixgroup
Slater Technologies
Smartcyber Group
Smoad
Sparkle
Swiss Financial Innovation Desk
Technology Innovation Institute (TII)
Thequantuminsider
Tobias Heindel
Tu Braunschweig
University College London
University of Bremen
University of Pisa
Venari Security
Veriqloud
Viavisolutions
Vodafone
Welinq
Wizzwang
Xairos
Youtube
Quside
QIZ
Global Quantum Intelligence
HYPATIA Smart Technologies
SAS
Triarii Research

Expert Membership

Builders, consultancies and technology vendors serving healthcare and life sciences: talk to us

Expert membership brings you into an open community working across sectors, opening up industry conversations, knowledge and access to experts. If you are building technology or consulting capabilities in this sector relevant to Quantum or Advanced AI, we want to hear from you.

  • Access to all Industry Conversations
  • Speaker opportunities at the annual Paris Symposium
  • Enhanced expert profile with lecture archive
  • Co-branding opportunities and social amplification
  • 25% off partner training and events

Everything you need, in one place

Our analysis for healthcare and life sciences

Policy and mandates

Questions leaders ask

Does HIPAA require post-quantum cryptography?

Not by name. The Security Rule requires technical safeguards that are reasonable and appropriate, and an accurate and thorough risk analysis under 45 CFR 164.308(a)(1)(ii)(A). HHS guidance points to NIST publications for what counts as appropriate encryption, and NIST IR 8547 deprecates RSA and ECC after 2030. The proposed rule of January 2025 would make encryption of ePHI mandatory with limited exceptions and require a technology asset inventory and network map. A risk analysis that ignores harvest now, decrypt later for long-lived ePHI is hard to defend as thorough.

What does the FDA require for cryptography in medical devices?

Section 524B of the FD&C Act, in force since 29 March 2023, requires premarket submissions for cyber devices to include a plan for postmarket vulnerabilities, reasonable assurance of cybersecurity and a software bill of materials. The premarket cybersecurity guidance reissued on 3 February 2026 recommends NIST-current cryptography that is expected to stay strong throughout the service life of the device, and no algorithms that are deprecated or disallowed under NIST SP 800-131A. For a device with a ten-year life filed from 2027, that points at ML-KEM and ML-DSA or a documented update path.

Why is genomic data the first priority for healthcare PQC migration?

A genome does not change, cannot be re-issued like a password, and describes the patient's relatives as well as the patient. Its confidentiality requirement has no end date, so any finite estimate of when a cryptographically relevant quantum computer arrives puts genomic data inside the harvest now, decrypt later window. Biobanks, national genomics programmes and research archives encrypted with RSA or ECC today should be re-encrypted or moved behind quantum-safe keys before anything else in the estate.

When do hospitals and health systems need to finish migrating?

The EU roadmap targets high-risk use cases by the end of 2030 and as many systems as feasible by 2035. NIST IR 8547 deprecates 112-bit RSA and ECC after 2030 and disallows them after 2035. The UK NCSC sets milestones at 2028, 2031 and 2035. Healthcare has a twist: a device bought in 2026 may still be on the ward in 2040, so procurement has to change years before the deadlines do.

Does NIS2 apply to hospitals, pharma and device makers?

Yes. Annex I of the NIS2 Directive lists the health sector among sectors of high criticality, including healthcare providers, EU reference laboratories, research and development of medicinal products, manufacturers of basic pharmaceutical products and manufacturers of medical devices considered critical during a public health emergency. Article 21(2)(h) requires policies on cryptography and encryption, and Article 20 makes management bodies approve and oversee the measures. Member states had until 17 October 2024 to transpose it.

What does the NHS expect on post-quantum cryptography?

There is no NHS-specific post-quantum mandate yet. The Data Security and Protection Toolkit assesses organisations against the National Data Guardian's standards with CAF-aligned audit guidance, and the DHSC cyber security strategy runs to 2030 without naming quantum. The NCSC timeline is the operative guidance for NHS organisations: discovery and a plan by 2028, high-priority migration by 2031, completion by 2035. GP records kept for ten years after death and maternity records kept for 25 years make the 2028 discovery date the one to plan around.

Where should a hospital start?

With three things: a cryptographic inventory of the systems that hold or move ePHI and of the connected device fleet, a map of which record types must stay confidential past 2030, and a written post-quantum roadmap from the EHR vendor and the cloud host behind it. Those three give the board the evidence to set priorities, and they are what the proposed HIPAA rule and NIS2 Article 21 already point towards.

Is quantum drug discovery real today?

It is real as research and not yet as a production tool. In June 2025 IonQ, AstraZeneca, AWS and NVIDIA simulated a step of a Suzuki-Miyaura reaction on a hybrid quantum and GPU stack and reported a more than 20-fold improvement in time to solution, a vendor-reported figure. Current hardware handles small active spaces, and no vendor offers fault-tolerant quantum chemistry for candidate screening. Boards should fund evaluation, not procurement, and keep the security migration on a separate budget line.

What should we show the board about quantum risk?

Five numbers: inventory coverage of ePHI systems and the device fleet, the records and patient counts that must stay confidential beyond 2030, how many EHR, cloud and device suppliers have a post-quantum roadmap on file, how many connected devices can change algorithm in the field or retire before 2035, and budget and milestones against the 2030 and 2035 deadlines.

What does QSECDEF offer hospitals, health systems, device makers and pharma for free?

Everything on this page. The two-minute readiness check scores your healthcare and life sciences programme and routes you to the right next step. The free tools, including the HNDL Risk Calculator and the Q-Day Timeline Risk Calculator, run in your browser with no registration. The weekly peer call runs every Tuesday at 15:00 CET and is open to anyone. Sample lectures from the 170-plus expert library are linked above, and the page is reviewed as the mandates change; the date beside the key facts is the last check.

Which QSECDEF course should a healthcare and life sciences team take first?

It depends on the role. Board and executives start with the Certified Quantum Business Professional bootcamp, about 22 hours self-paced across ten modules. Security, IT and clinical engineering teams take Introduction to Quantum Cyber Security, four to five hours online with a QSECDEF certificate. GRC, privacy and compliance leads take AI Security and Resilience Leadership Bootcamp, twenty live online lectures connecting AI security, resilience and post-quantum readiness. Whoever will run the migration takes CPQCPM, the Certified Post Quantum Cryptography Programme Manager course: ten hours live online over five weeks, with the next public cohort in January 2027.

Can QSECDEF run private training or a workshop for our hospital, health system, device maker or pharma company?

Yes. QSECDEF runs private CPQCPM cohorts for a single organisation, live online or in person, and private deliveries of the sector courses listed under Equip your people for your GRC, privacy and clinical engineering teams. Board and leadership workshops are built on your own exposure and obligations and end with an agreed position on quantum risk. Use the contact button in the For your organisation section and tell us your timeline.

How do we find vetted suppliers or consultants for a healthcare and life sciences PQC migration?

Through the QSECDEF Expert Members directory. Every listed member has been vetted, has signed the Members' Charter and has presented to the community. You can filter by consulting and services, technology vendor or enablement and investment, and send a request for further information from the member's own page. QSECDEF is vendor-neutral and sells training, not migration products, so the shortlist stays yours.

Is QSECDEF membership relevant to a hospital, health system, device maker or pharma company?

Two routes. QSECDEF membership gives your team the self-paced courses, the full lecture archive, the weekly call and 25 per cent off CPQCPM and partner training. Expert Membership is for the builders, consultancies and technology vendors serving healthcare and life sciences who want to be found by the people reading this page; it includes a showcase listing with an enquiry form, the Industry Conversations and speaking slots at the annual QSECDEF symposium.

Is QSECDEF selling a migration product?

No. QSECDEF is a vendor-neutral membership network. We train people and connect them with peers and peer-reviewed experts; we do not sell migration software or services.

How much time does the training take?

CPQCPM is ten hours of live instruction over five weeks, two hours a week. The Quantum Cyber Security course is 4 to 5 hours, self-paced. The business bootcamp is self-paced at your own speed. The healthcare workshops are full-day sessions, in person or online.

Ask a practitioner, live

The free weekly call runs every Tuesday at 15:00 CET. Bring your question.

Join the Tuesday call →
A long, brightly lit hospital corridor

For your organisation

Need it built around your organisation?

When your board, programme team, notified body or auditor needs something specific, we shape the workshop, the training or the engagement around your systems, your regulators and your timeline. Independent of any vendor.

Custom workshops

Your board leaves with an agreed position on quantum risk

Facilitated sessions for boards, audit and risk committees and clinical technology leadership, built on your own record types, device fleet, obligations and 2030 plan.

Private training

Your whole team trained on one plan

Private CPQCPM cohorts, live online or in person, with the seven healthcare workshops for EHR migration, device security, trial data and genomic data, and team membership for the self-paced courses.

Consulting

A migration programme specified and staffed correctly

Cryptographic inventory, PQC migration planning, EHR and device vendor review and specialist teams sourced from 1,500+ members across 900+ organisations.

Prefer email? Write to info@qsecdef.com and tell us about your timeline.

Photos: Pexels (Marlon Castor, MART PRODUCTION, cottonbro studio, Elements Interactive, Odin Reyna, Enrique Silva, Thirdman) and QSECDEF, converted to black and white or brand duotone.